Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression
about
Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejectionGene therapy: light is finally in the tunnelTissue engineering tools for modulation of the immune responseGutless adenovirus: last-generation adenovirus for gene therapyAdenoviral vector immunity: its implications and circumvention strategies.Current methods for detecting antibodies against erythropoietin and other recombinant proteins.Induction of immune tolerance to FIX by intramuscular AAV gene transfer is independent of the activation status of dendritic cells.Systemic and central nervous system correction of lysosomal storage in mucopolysaccharidosis type VII miceAdenoviral Vectors for Hemophilia Gene TherapyReview--the use of immunosuppressive agents to prevent neutralizing antibodies against a transgene product.Role of alpha(v) integrins in adenovirus cell entry and gene delivery.Identification of sites in adenovirus hexon for foreign peptide incorporation.Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.Progress in cancer gene therapy.Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB.In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.Circumvention of immunity to the adenovirus major coat protein hexon.Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administrationConstruction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes.Innate immune recognition of viruses and viral vectors.Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organsEffects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3.Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systemsReplication-defective bovine adenovirus type 3 as an expression vectorGene and cell-mediated therapies for muscular dystrophy.Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate model.Gene therapy in the CNS.In situ use of suicide genes for therapy of brain tumours.Gene therapy: design and prospects for craniofacial regeneration.Gene therapy: development of immunostimulatory treatments for cancer.Haemophilias: advances towards genetic engineering replacement therapy.Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product.Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon.Local gene delivery to the vessel wall.NKG2D is required for NK cell activation and function in response to E1-deleted adenovirusLDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives
P2860
Q24630780-3C2AFD95-7902-499C-9E0A-B3F46BEA3042Q27000091-75C92074-FC45-4723-B119-0F6F0842A141Q27023419-BDE5566A-9DB5-4361-95B7-1EBCC271C3A3Q28277560-F891BF8A-4195-4620-8F31-8434CDCC0521Q33565630-09F822F1-4154-445B-AE1F-EE332FAA4DF9Q33593537-195FD45F-AB44-429C-B44D-C4E1D5D04FF7Q33608746-BE3C0467-9DFB-4E54-BF95-17DFA802AFE9Q33645370-A972C26E-E546-466B-A552-DB95843A444BQ33690648-2A56DCFB-E528-411A-8D91-AE1943093766Q33692535-6DA03CB5-E70E-436B-B98C-A914E759B691Q33728794-B4D48CF3-784A-42C0-BE40-F8B06C994780Q33737591-2E2480F9-5730-4343-84FA-E00FD263CDFEQ33745707-B25E4DD5-47A0-4DF6-A9E3-AAB81B483A94Q33752288-26529259-26C7-4D31-B3DE-8CE56B0AD2DEQ33781921-CAA4B7CD-9B04-40E9-BD10-C4A3614B8AAFQ33782356-5D89DF9F-DC2C-4B7A-97CD-ADAFC2B63891Q33783658-89C686C5-4E31-426D-A8A3-529B0200A543Q33783991-86DFDF43-F310-4AF6-B836-363209325D09Q33786378-20316325-7814-436F-A699-02BABF9CDBAEQ33804205-BD4FC0D2-A02B-4E04-8A4D-E95243D46522Q33805229-9E743B58-D798-4C2A-9AE3-8987D0CEC9A9Q33813779-F008464C-4019-4EF7-AECF-6372F65263A9Q33815920-6CBF31E5-74D8-4160-8757-334BF2F4E272Q33817535-F197C2A0-8711-4FE4-A655-923F9CD2AD25Q33818929-4294C8AD-60BA-4751-AEDC-19A2DA3D9D9AQ33819873-0F96B4E6-95C9-496B-9767-60FF95C001ABQ33821596-7FC31606-0148-451E-9DF2-85A5008AFCA0Q33822773-5D0A534D-AA4F-4B79-AE13-F971CD316CA3Q33831193-E8CE3CF1-3D36-4655-A99D-CDAC12DE6FC1Q33835521-B6AAB9F2-8350-49EA-94C3-FCD64EB0A243Q33837123-A392CBB3-F482-4A72-B94D-1A628F3A74B1Q33841658-7C2C5123-B47C-49B2-B018-4CD66F02E4CCQ34007347-ADFCF2D7-2E61-4FF5-B5E0-77E9275319ECQ34187915-4DA9E38A-4D2B-42C6-91CD-5F8DA61F642AQ34229310-1E6B5850-7745-4D22-8ECF-3A7DAC3335C0Q34333200-ECB6400C-24E7-47F4-BDA0-ABA8E554CE40Q34352485-D0FE61EC-F344-4028-9CC1-822E9A2C6F72Q34418987-08FCA374-409D-4092-9590-7A33BD2BEF29Q34432661-40D5872A-0AE0-4ACF-8062-10F4AE2B024DQ34467839-6D06EF90-C5DF-4DD9-BDEA-DEDCC4B722F2
P2860
Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Cellular and humoral immune re ...... llows for long-term expression
@ast
Cellular and humoral immune re ...... llows for long-term expression
@en
Cellular and humoral immune re ...... llows for long-term expression
@nl
type
label
Cellular and humoral immune re ...... llows for long-term expression
@ast
Cellular and humoral immune re ...... llows for long-term expression
@en
Cellular and humoral immune re ...... llows for long-term expression
@nl
prefLabel
Cellular and humoral immune re ...... llows for long-term expression
@ast
Cellular and humoral immune re ...... llows for long-term expression
@en
Cellular and humoral immune re ...... llows for long-term expression
@nl
P2093
P2860
P356
P1476
Cellular and humoral immune re ...... llows for long-term expression
@en
P2093
P2860
P304
P356
10.1073/PNAS.92.5.1401
P407
P577
1995-02-01T00:00:00Z